Calcitonin Gene-related Peptide Receptor Antagonist [EPC]

Calcitonin Gene-related Peptide Receptor Antagonist [EPC] was reported 6969 times

Drugs of the Calcitonin Gene-related Peptide Receptor Antagonist [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 CERVICOGENIC HEADACHE 18 0.1324
1 PINEAL GLAND CYST 18 0.1286
2 HABITUAL ABORTION 13 0.1140
3 MIGRAINE WITHOUT AURA 25 0.0833
4 HEMIPLEGIC MIGRAINE 20 0.0590
5 VESTIBULAR MIGRAINE 9 0.0373
6 STATUS MIGRAINOSUS 5 0.0311
7 OCCIPITAL NEURALGIA 15 0.0265
8 PSEUDOSTROKE 9 0.0262
9 TEMPOROMANDIBULAR PAIN AND DYSFUNCTION SYNDROME 11 0.0258
10 ILIOTIBIAL BAND SYNDROME 5 0.0221
11 OPHTHALMIC MIGRAINE 15 0.0216
12 MIGRAINE 2018 0.0211
13 NERVE BLOCK 10 0.0171
14 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 23 0.0170
15 MEDICATION OVERUSE HEADACHE 14 0.0164
16 CHILLBLAINS 4 0.0153
17 EHLERS-DANLOS SYNDROME 7 0.0151
18 POST CONCUSSION SYNDROME 5 0.0147
19 LUMBAR PUNCTURE 5 0.0132
20 PHONOPHOBIA 6 0.0130
21 AURA 24 0.0129
22 BRAIN OPERATION 29 0.0127
23 VOCAL CORD DYSFUNCTION 6 0.0122
24 CLUSTER HEADACHE 16 0.0117
25 MAST CELL ACTIVATION SYNDROME 16 0.0114
26 MIGRAINE WITH AURA 29 0.0107
27 TENSION HEADACHE 42 0.0098
28 ALLERGY TO PLANTS 4 0.0088
29 PSYCHOGENIC SEIZURE 8 0.0086
30 INFUSION SITE DISCHARGE 15 0.0085
31 PRODUCT ADMINISTRATION INTERRUPTED 65 0.0083
32 NECK SURGERY 19 0.0082
33 MEDICAL PROCEDURE 13 0.0078
34 CEREBROSPINAL FLUID LEAKAGE 14 0.0076
35 AUTOSCOPY 4 0.0074
36 INFUSION SITE BRUISING 16 0.0074
37 GIANT CELL ARTERITIS 6 0.0072
38 IDIOPATHIC INTRACRANIAL HYPERTENSION 16 0.0071
39 CERVICAL RADICULOPATHY 5 0.0070
40 THERAPEUTIC PRODUCT EFFECT DELAYED 30 0.0066
41 ARNOLD-CHIARI MALFORMATION 6 0.0063
42 OBSTRUCTIVE SLEEP APNOEA SYNDROME 9 0.0062
43 BRAIN FOG 94 0.0060
44 INTRUSIVE THOUGHTS 7 0.0059
45 THERAPEUTIC PRODUCT EFFECT VARIABLE 23 0.0059
46 CEREBRAL CYST 4 0.0058
47 TONGUE PRURITUS 5 0.0058
48 CERVICAL SPINAL STENOSIS 10 0.0058
49 POST-ACUTE COVID-19 SYNDROME 7 0.0056
50 FACIAL DISCOMFORT 4 0.0056
51 OOPHORECTOMY 5 0.0056
52 SPINAL OPERATION 65 0.0053
53 IMPAIRED GASTRIC EMPTYING 69 0.0051
54 SINUS OPERATION 12 0.0050
55 THERAPEUTIC RESPONSE DELAYED 14 0.0050
56 BREAST OPERATION 4 0.0049
57 HYPERACUSIS 18 0.0048
58 INTERVERTEBRAL DISC OPERATION 6 0.0048
59 ALLERGY TO CHEMICALS 6 0.0048
60 INFUSION SITE PRURITUS 15 0.0047
61 THERAPEUTIC RESPONSE SHORTENED 154 0.0046
62 ESSENTIAL TREMOR 5 0.0045
63 MEDICAL DEVICE IMPLANTATION 7 0.0045
64 CONCUSSION 34 0.0044
65 INFUSION SITE RASH 6 0.0044
66 PREMENSTRUAL SYNDROME 6 0.0044
67 CYSTITIS INTERSTITIAL 7 0.0043
68 LUMBAR RADICULOPATHY 5 0.0043
69 LYMPH NODE PAIN 8 0.0043
70 CRANIOCEREBRAL INJURY 13 0.0043
71 JC POLYOMAVIRUS TEST POSITIVE 5 0.0043
72 CEREBRAL PALSY 4 0.0042
73 RECTAL PROLAPSE 5 0.0041
74 INTERMENSTRUAL BLEEDING 23 0.0041
75 CEREBRAL ARTERY EMBOLISM 5 0.0041
76 ANKLE OPERATION 6 0.0041
77 HYSTERECTOMY 35 0.0040
78 POST-TRAUMATIC STRESS DISORDER 27 0.0040
79 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 286 0.0040
80 SHOULDER OPERATION 17 0.0040
81 LIMB OPERATION 19 0.0040
82 TERMINAL INSOMNIA 7 0.0040
83 OVARIAN CYST RUPTURED 5 0.0039
84 SINUS PAIN 9 0.0039
85 ABDOMINAL OPERATION 5 0.0038
86 BACTERIAL VAGINOSIS 6 0.0038
87 ALLERGY TO ANIMAL 4 0.0038
88 SPINAL FUSION SURGERY 15 0.0037
89 MOTION SICKNESS 7 0.0036
90 BRAIN NEOPLASM 33 0.0036
91 ELECTRIC SHOCK SENSATION 10 0.0036
92 CHEMICAL BURN 4 0.0035
93 THERAPY INTERRUPTED 247 0.0035
94 FOOT OPERATION 17 0.0034
95 ALLODYNIA 4 0.0034
96 SLEEP PARALYSIS 5 0.0034
97 COMPLEX REGIONAL PAIN SYNDROME 5 0.0034
98 HEAVY MENSTRUAL BLEEDING 30 0.0033
99 MULTIPLE ALLERGIES 26 0.0033
100 UTERINE SPASM 6 0.0033
101 FOOD ALLERGY 25 0.0032
102 FEELING DRUNK 24 0.0032
103 PRODUCT USE COMPLAINT 50 0.0032
104 DRUG EFFECT LESS THAN EXPECTED 46 0.0031
105 AUTONOMIC NERVOUS SYSTEM IMBALANCE 9 0.0031
106 SHOULDER FRACTURE 5 0.0031
107 ABNORMAL SLEEP-RELATED EVENT 4 0.0030
108 TONSILLECTOMY 5 0.0030
109 SHOULDER ARTHROPLASTY 8 0.0030
110 KNEE OPERATION 29 0.0029
111 PHOTOPHOBIA 55 0.0029
112 SURGERY 171 0.0029
113 FACE INJURY 11 0.0029
114 PRE-EXISTING CONDITION IMPROVED 18 0.0029
115 SPINAL CORD INJURY 5 0.0029
116 DISABILITY 56 0.0028
117 PANCREATIC FAILURE 5 0.0028
118 FAECES HARD 11 0.0028
119 GLUTEN SENSITIVITY 4 0.0028
120 CONSTIPATION 605 0.0028
121 HYPERTONIC BLADDER 8 0.0028
122 GASTRIC BYPASS 6 0.0028
123 OLIGOMENORRHOEA 6 0.0027
124 INFUSION SITE HAEMORRHAGE 9 0.0027
125 ENDOMETRIOSIS 13 0.0027
126 CEREBRAL DISORDER 20 0.0027
127 THERAPEUTIC PRODUCT EFFECT DECREASED 121 0.0027
128 ATTENTION DEFICIT HYPERACTIVITY DISORDER 11 0.0026
129 HEAD DISCOMFORT 46 0.0026
130 VULVOVAGINAL MYCOTIC INFECTION 10 0.0025
131 FACIAL PARALYSIS 21 0.0025
132 DENTAL IMPLANTATION 4 0.0024
133 GASTROINTESTINAL MOTILITY DISORDER 13 0.0024
134 DEVICE INFUSION ISSUE 6 0.0024
135 LIVEDO RETICULARIS 5 0.0024
136 LIVE BIRTH 20 0.0024
137 INFUSION SITE SWELLING 15 0.0024
138 FEEDING DISORDER 48 0.0024
139 SLEEP DEFICIT 5 0.0024
140 THYROID MASS 9 0.0023
141 INTRACRANIAL PRESSURE INCREASED 13 0.0023
142 DEREALISATION 5 0.0023
143 UPPER-AIRWAY COUGH SYNDROME 19 0.0023
144 PRODUCT PACKAGING DIFFICULT TO OPEN 6 0.0023
145 PERIORBITAL SWELLING 13 0.0023
146 HANGOVER 8 0.0023
147 ACCIDENT AT WORK 5 0.0023
148 APPENDICECTOMY 8 0.0022
149 CARDIAC ABLATION 4 0.0022
150 GASTROINTESTINAL HYPOMOTILITY 5 0.0022
151 EYE OPERATION 10 0.0022
152 PARAESTHESIA ORAL 31 0.0021
153 ORAL SURGERY 5 0.0021
154 INFUSION SITE ERYTHEMA 18 0.0021
155 SNORING 8 0.0021
156 LYME DISEASE 7 0.0021
157 INSURANCE ISSUE 32 0.0021
158 BLOOD IMMUNOGLOBULIN E INCREASED 5 0.0021
159 MENSTRUAL DISORDER 17 0.0021
160 SEASONAL ALLERGY 29 0.0020
161 HIP SURGERY 11 0.0020
162 DEPRESSION SUICIDAL 7 0.0020
163 BRAIN INJURY 20 0.0020
164 VERTIGO 120 0.0020
165 ILLNESS 201 0.0019
166 NERVE COMPRESSION 18 0.0019
167 KNEE ARTHROPLASTY 41 0.0019
168 PHARYNGEAL SWELLING 19 0.0019
169 MENOPAUSE 5 0.0019
170 COELIAC DISEASE 19 0.0019
171 SELF-INJURIOUS IDEATION 8 0.0019
172 PERIPHERAL COLDNESS 26 0.0019
173 HEADACHE 1180 0.0019
174 INCORRECT DRUG ADMINISTRATION RATE 8 0.0019
175 ANIMAL BITE 5 0.0019
176 INFUSION SITE PAIN 24 0.0019
177 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 89 0.0019
178 PARANASAL SINUS DISCOMFORT 7 0.0018
179 INCORRECT DISPOSAL OF PRODUCT 6 0.0018
180 HORMONE LEVEL ABNORMAL 9 0.0018
181 INTENTIONAL DOSE OMISSION 52 0.0018
182 TRICHORRHEXIS 5 0.0018
183 COLECTOMY 10 0.0018
184 FIBROMYALGIA 43 0.0018
185 THERAPEUTIC RESPONSE DECREASED 107 0.0018
186 IMPAIRED DRIVING ABILITY 20 0.0018
187 DERMATITIS CONTACT 20 0.0018
188 CERVICAL VERTEBRAL FRACTURE 6 0.0017
189 EYELID DISORDER 4 0.0017
190 PARTIAL SEIZURES 9 0.0017
191 FOOD POISONING 9 0.0017
192 IMPAIRED QUALITY OF LIFE 24 0.0017
193 BRUXISM 9 0.0017
194 SEIZURE 190 0.0016
195 AUTOIMMUNE DISORDER 16 0.0016
196 FOOD INTOLERANCE 6 0.0016
197 TINNITUS 75 0.0016
198 SUICIDAL IDEATION 149 0.0016
199 BLINDNESS TRANSIENT 12 0.0016
200 PANCREATIC DISORDER 8 0.0016
201 HORDEOLUM 7 0.0016
202 EYE PAIN 90 0.0016
203 ENDODONTIC PROCEDURE 4 0.0016
204 NEUROLOGICAL SYMPTOM 9 0.0016
205 PARANASAL SINUS HYPERSECRETION 6 0.0016
206 ILEUS PARALYTIC 7 0.0016
207 COVID-19 274 0.0016
208 ROTATOR CUFF SYNDROME 20 0.0016
209 OROPHARYNGEAL DISCOMFORT 14 0.0015
210 NEPHROLITHIASIS 71 0.0015
211 CATHETER SITE PAIN 4 0.0015
212 THROAT IRRITATION 69 0.0015
213 PANIC ATTACK 56 0.0015
214 SINUS HEADACHE 9 0.0015
215 PRODUCT DISTRIBUTION ISSUE 14 0.0015
216 APPETITE DISORDER 10 0.0015
217 MAJOR DEPRESSION 11 0.0015
218 OBSTRUCTION 6 0.0015
219 INTRACRANIAL ANEURYSM 6 0.0015
220 COMPRESSION FRACTURE 8 0.0015
221 TRIGEMINAL NEURALGIA 6 0.0015
222 CLUMSINESS 4 0.0015
223 SOMNOLENCE 294 0.0015
224 HYPOAESTHESIA ORAL 22 0.0015
225 POST PROCEDURAL COMPLICATION 28 0.0015
226 PAROSMIA 11 0.0015
227 NECK PAIN 81 0.0014
228 IRRITABLE BOWEL SYNDROME 31 0.0014
229 TACHYPHRENIA 5 0.0014
230 GASTROENTERITIS VIRAL 26 0.0014
231 FORMICATION 10 0.0014
232 ADVERSE DRUG REACTION 129 0.0014
233 NAUSEA 1135 0.0014
234 PHOTOPSIA 9 0.0014
235 DEPRESSIVE SYMPTOM 5 0.0014
236 INTERVERTEBRAL DISC PROTRUSION 31 0.0014
237 ANEURYSM 7 0.0014
238 INTERVERTEBRAL DISC DISORDER 6 0.0014
239 HEREDITARY ANGIOEDEMA 15 0.0014
240 MOUTH SWELLING 8 0.0014
241 PALPITATIONS 162 0.0014
242 EYELID PTOSIS 14 0.0014
243 ABNORMAL DREAMS 38 0.0014
244 SPONDYLITIS 5 0.0014
245 DYSPHEMIA 6 0.0014
246 GASTROINTESTINAL PAIN 15 0.0014
247 SINUS DISORDER 27 0.0014
248 DRUG INEFFECTIVE 1792 0.0014
249 PARADOXICAL DRUG REACTION 5 0.0014
250 LIGAMENT RUPTURE 6 0.0014
251 APHASIA 41 0.0014
252 FACIAL PAIN 12 0.0013
253 NEURODERMATITIS 5 0.0013
254 PRODUCT DOSE OMISSION IN ERROR 38 0.0013
255 SINUS CONGESTION 18 0.0013
256 THROAT TIGHTNESS 36 0.0013
257 TASTE DISORDER 27 0.0013
258 AUTOIMMUNE THYROIDITIS 5 0.0013
259 VASCULAR DEVICE INFECTION 6 0.0013
260 CHEMOTHERAPY 5 0.0013
261 NOCTURIA 16 0.0013
262 EYE INJURY 4 0.0013
263 DYSCHEZIA 4 0.0013
264 SLEEP APNOEA SYNDROME 25 0.0013
265 CLAVICLE FRACTURE 5 0.0013
266 NEOPLASM 15 0.0013
267 LYMPHOEDEMA 9 0.0013
268 OESOPHAGEAL DISORDER 5 0.0013
269 VITAMIN D DECREASED 11 0.0013
270 INFUSION SITE EXTRAVASATION 8 0.0013
271 ASTHENOPIA 7 0.0013
272 AFFECTIVE DISORDER 10 0.0013
273 PHOTOSENSITIVITY REACTION 21 0.0013
274 EUPHORIC MOOD 13 0.0013
275 INITIAL INSOMNIA 13 0.0013
276 IMPAIRED WORK ABILITY 27 0.0013
277 FEAR OF INJECTION 9 0.0013
278 HEART RATE ABNORMAL 7 0.0013
279 ACCIDENTAL UNDERDOSE 18 0.0012
280 OCULAR DISCOMFORT 14 0.0012
281 DEVICE DIFFICULT TO USE 82 0.0012
282 GALLBLADDER OPERATION 5 0.0012
283 THINKING ABNORMAL 23 0.0012
284 NEURALGIA 30 0.0012
285 MIDDLE INSOMNIA 23 0.0012
286 FACET JOINT SYNDROME 4 0.0012
287 VITREOUS FLOATERS 12 0.0012
288 ROAD TRAFFIC ACCIDENT 51 0.0012
289 SOMNAMBULISM 8 0.0012
290 DEAFNESS NEUROSENSORY 4 0.0012
291 ARTHROPOD BITE 9 0.0012
292 SPINAL STENOSIS 5 0.0012
293 BLINDNESS UNILATERAL 17 0.0012
294 EAR INFECTION 32 0.0012
295 HEMIPLEGIA 10 0.0012
296 HEAD INJURY 38 0.0012
297 PAIN IN JAW 34 0.0012
298 FEELING OF BODY TEMPERATURE CHANGE 7 0.0012
299 HALLUCINATIONS, MIXED 5 0.0012
300 INTERVERTEBRAL DISC DEGENERATION 11 0.0012
301 THERAPEUTIC RESPONSE UNEXPECTED 53 0.0012
302 TONGUE DISCOMFORT 5 0.0012
303 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 20 0.0012
304 FEELING ABNORMAL 282 0.0012
305 PETIT MAL EPILEPSY 6 0.0012
306 POOR PERIPHERAL CIRCULATION 5 0.0012
307 ABNORMAL LOSS OF WEIGHT 8 0.0012
308 UTERINE HAEMORRHAGE 5 0.0012
309 HEPATIC PAIN 5 0.0012
310 GAIT INABILITY 39 0.0012
311 PRODUCT DOSE OMISSION ISSUE 343 0.0012
312 NASAL CONGESTION 68 0.0012
313 MALABSORPTION 6 0.0011
314 UPPER RESPIRATORY TRACT INFECTION 53 0.0011
315 SENSITIVITY TO WEATHER CHANGE 6 0.0011
316 PRODUCT PHYSICAL ISSUE 23 0.0011
317 POOR QUALITY PRODUCT ADMINISTERED 12 0.0011
318 TENDON RUPTURE 14 0.0011
319 MUSCLE TWITCHING 26 0.0011
320 MATERNAL EXPOSURE DURING PREGNANCY 100 0.0011
321 BRAIN NEOPLASM MALIGNANT 5 0.0011
322 SWELLING OF EYELID 7 0.0011
323 FRUSTRATION TOLERANCE DECREASED 9 0.0011
324 FACIAL BONES FRACTURE 4 0.0011
325 DEAFNESS 29 0.0011
326 PANIC REACTION 8 0.0011
327 MENSTRUATION DELAYED 12 0.0011
328 POST PROCEDURAL INFECTION 9 0.0011
329 FEELING JITTERY 21 0.0011
330 DRY EYE 55 0.0011
331 ANKLE FRACTURE 17 0.0011
332 HAEMOGLOBIN INCREASED 5 0.0011
333 BLOOD IRON DECREASED 13 0.0011
334 FAECALOMA 6 0.0011
335 UTERINE LEIOMYOMA 8 0.0011
336 ACCIDENT 13 0.0011
337 AMENORRHOEA 19 0.0011
338 CARDIAC FLUTTER 7 0.0011
339 MENSTRUATION IRREGULAR 29 0.0011
340 EAR PAIN 21 0.0011
341 MOTOR DYSFUNCTION 11 0.0011
342 JOINT INJURY 23 0.0011
343 GASTROINTESTINAL DISORDER 96 0.0011
344 SENSATION OF FOREIGN BODY 9 0.0011
345 SUSPECTED SUICIDE 5 0.0011
346 TEMPERATURE INTOLERANCE 11 0.0011
347 CHRONIC SINUSITIS 4 0.0011
348 BEDRIDDEN 14 0.0011
349 CHEST DISCOMFORT 109 0.0011
350 EYE INFECTION 12 0.0011
351 HEART RATE INCREASED 105 0.0011
352 DIZZINESS 528 0.0011
353 SKIN ABRASION 5 0.0011
354 BLOOD PRESSURE ABNORMAL 21 0.0011
355 MUSCULOSKELETAL DISORDER 20 0.0010
356 BREAST CANCER FEMALE 28 0.0010
357 CARDIAC OPERATION 9 0.0010
358 MUSCULOSKELETAL DISCOMFORT 18 0.0010
359 DISSOCIATION 8 0.0010
360 NIGHTMARE 36 0.0010
361 MUSCLE STRAIN 9 0.0010
362 LOSS OF CONSCIOUSNESS 133 0.0010
363 PRODUCT TASTE ABNORMAL 14 0.0010
364 DECREASED APPETITE 240 0.0010
365 PRODUCT LABEL ISSUE 7 0.0010
366 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 208 0.0010
367 VITAMIN D DEFICIENCY 10 0.0010
368 SPINAL OSTEOARTHRITIS 9 0.0010
369 EPIGASTRIC DISCOMFORT 4 0.0010
370 EYE SWELLING 38 0.0010
371 KIDNEY INFECTION 20 0.0010
372 INJECTION SITE URTICARIA 25 0.0010
373 GASTROOESOPHAGEAL REFLUX DISEASE 82 0.0010
374 THERAPY CHANGE 10 0.0010
375 FATIGUE 790 0.0010
376 SYSTEMIC LUPUS ERYTHEMATOSUS 36 0.0010
377 ANXIETY 288 0.0010
378 SKIN LACERATION 11 0.0010
379 LIGAMENT SPRAIN 10 0.0010
380 NASAL DISCOMFORT 8 0.0010
381 HYPOAESTHESIA 151 0.0010
382 ASTHMA 114 0.0010
383 SINUSITIS 103 0.0010
384 PARAESTHESIA 158 0.0010
385 CEREBROVASCULAR ACCIDENT 170 0.0010
386 HEPATIC ENZYME ABNORMAL 5 0.0010
387 WRIST FRACTURE 12 0.0010
388 OBSESSIVE-COMPULSIVE DISORDER 8 0.0010
389 FOOT DEFORMITY 11 0.0010
390 MYASTHENIA GRAVIS 8 0.0010
391 BACK DISORDER 16 0.0010
392 ALOPECIA 193 0.0010
393 DISTURBANCE IN ATTENTION 53 0.0010
394 HERNIA 19 0.0010
395 SNEEZING 22 0.0010
396 HIP ARTHROPLASTY 15 0.0010
397 PARALYSIS 14 0.0010
398 EAR DISCOMFORT 10 0.0010
399 VARICOSE VEIN 5 0.0010
400 MEMORY IMPAIRMENT 133 0.0010
401 TOOTH EXTRACTION 12 0.0010
402 BLINDNESS 39 0.0010
403 SEDATION 25 0.0010
404 VISION BLURRED 131 0.0010
405 BLEPHAROSPASM 6 0.0010
406 SPINAL DISORDER 9 0.0009
407 MENTAL IMPAIRMENT 23 0.0009
408 TRANSIENT ISCHAEMIC ATTACK 32 0.0009
409 EYE INFLAMMATION 9 0.0009
410 SUPRAVENTRICULAR TACHYCARDIA 9 0.0009
411 SPINAL PAIN 11 0.0009
412 APHONIA 13 0.0009
413 INJECTION SITE DISCHARGE 5 0.0009
414 SWOLLEN TONGUE 29 0.0009
415 DEPRESSED MOOD 49 0.0009
416 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 167 0.0009
417 MULTIPLE SCLEROSIS 44 0.0009
418 BOWEL MOVEMENT IRREGULARITY 7 0.0009
419 DRY MOUTH 74 0.0009
420 ABDOMINAL DISTENSION 95 0.0009
421 GRIP STRENGTH DECREASED 8 0.0009
422 ABDOMINAL PAIN UPPER 187 0.0009
423 PRODUCT COMMUNICATION ISSUE 8 0.0009
424 CATHETERISATION CARDIAC 4 0.0009
425 PROCEDURAL PAIN 25 0.0009
426 NERVE INJURY 10 0.0009
427 UNEVALUABLE EVENT 68 0.0009
428 FOOT FRACTURE 17 0.0009
429 DRUG DOSE OMISSION BY DEVICE 70 0.0009
430 MALNUTRITION 10 0.0009
431 SKIN INFECTION 10 0.0009
432 BRONCHIECTASIS 6 0.0009
433 POSTOPERATIVE WOUND INFECTION 6 0.0009
434 ULCER HAEMORRHAGE 6 0.0009
435 WEIGHT DECREASED 247 0.0009
436 POOR QUALITY SLEEP 19 0.0009
437 BLOOD THYROID STIMULATING HORMONE DECREASED 4 0.0009
438 MOOD ALTERED 24 0.0009
439 HIDRADENITIS 8 0.0009
440 EYE MOVEMENT DISORDER 6 0.0009
441 HYPERSOMNIA 25 0.0009
442 POOR VENOUS ACCESS 9 0.0009
443 NEOPLASM MALIGNANT 58 0.0009
444 INSOMNIA 231 0.0009
445 DYSPEPSIA 85 0.0009
446 FEELING COLD 24 0.0009
447 FEELING OF DESPAIR 4 0.0009
448 HYPERAESTHESIA 7 0.0009
449 COLD SWEAT 15 0.0009
450 INJECTION SITE PRURITUS 57 0.0009
451 DECREASED INTEREST 5 0.0008
452 EATING DISORDER 18 0.0008
453 PRODUCT SUPPLY ISSUE 6 0.0008
454 LIVER FUNCTION TEST INCREASED 18 0.0008
455 ODYNOPHAGIA 5 0.0008
456 SLEEP DISORDER 59 0.0008
457 VOMITING 391 0.0008
458 PHARYNGITIS STREPTOCOCCAL 9 0.0008
459 INTESTINAL OBSTRUCTION 31 0.0008
460 EYE DISORDER 27 0.0008
461 SPEECH DISORDER 43 0.0008
462 CHEST PAIN 152 0.0008
463 TOOTH FRACTURE 9 0.0008
464 ANAPHYLACTIC REACTION 45 0.0008
465 COGNITIVE DISORDER 38 0.0008
466 SENSITIVE SKIN 6 0.0008
467 VIRAL INFECTION 27 0.0008
468 TREMOR 134 0.0008
469 GASTROINTESTINAL SOUNDS ABNORMAL 4 0.0008
470 HEPATIC STEATOSIS 15 0.0008
471 SUNBURN 6 0.0008
472 DEPRESSION 183 0.0008
473 RESPIRATORY SYNCYTIAL VIRUS INFECTION 7 0.0008
474 PRODUCT USE ISSUE 151 0.0008
475 GENERAL SYMPTOM 6 0.0008
476 FLUID INTAKE REDUCED 4 0.0008
477 PREGNANCY 16 0.0008
478 HYPERTENSION 169 0.0008
479 HUNGER 11 0.0008
480 DYSLIPIDAEMIA 4 0.0008
481 BALANCE DISORDER 68 0.0008
482 FOREIGN BODY SENSATION IN EYES 5 0.0008
483 VISUAL IMPAIRMENT 97 0.0008
484 INJECTION SITE WARMTH 16 0.0008
485 RIB FRACTURE 16 0.0008
486 APHTHOUS ULCER 6 0.0008
487 HIATUS HERNIA 10 0.0008
488 BRONCHOSPASM 11 0.0008
489 EYE DISCHARGE 8 0.0008
490 TENDON DISORDER 5 0.0008
491 FEELING HOT 47 0.0008
492 BLOOD POTASSIUM DECREASED 23 0.0008
493 EYE IRRITATION 44 0.0008
494 ARTERIAL OCCLUSIVE DISEASE 6 0.0008
495 LYMPHADENOPATHY 27 0.0008
496 PRURITUS 293 0.0008
497 INCREASED TENDENCY TO BRUISE 7 0.0008
498 GASTRITIS 20 0.0008
499 SCAR 13 0.0008
500 ABDOMINAL DISCOMFORT 127 0.0008
501 RESPIRATORY TRACT CONGESTION 12 0.0008
502 DYSMENORRHOEA 10 0.0008
503 APPENDICITIS 7 0.0007
504 MENINGITIS 5 0.0007
505 DYSPHAGIA 71 0.0007
506 ORTHOSTATIC HYPOTENSION 13 0.0007
507 RHINITIS 6 0.0007
508 LIMB DISCOMFORT 23 0.0007
509 CRYING 27 0.0007
510 PRODUCT ADMINISTRATION ERROR 15 0.0007
511 PULMONARY MASS 11 0.0007
512 SWELLING FACE 48 0.0007
513 BIPOLAR DISORDER 8 0.0007
514 URTICARIA 123 0.0007
515 MATERNAL EXPOSURE BEFORE PREGNANCY 5 0.0007
516 DIPLOPIA 19 0.0007
517 HICCUPS 6 0.0007
518 RESPIRATORY TRACT INFECTION 19 0.0007
519 THIRST 13 0.0007
520 DEAFNESS UNILATERAL 4 0.0007
521 RESPIRATION ABNORMAL 5 0.0007
522 DENTAL CARIES 8 0.0007
523 THERAPY CESSATION 37 0.0007
524 ORAL HERPES 14 0.0007
525 EXTRASYSTOLES 5 0.0007
526 BRONCHITIS 53 0.0007
527 MASS 10 0.0007
528 RESTLESS LEGS SYNDROME 13 0.0007
529 CARPAL TUNNEL SYNDROME 10 0.0007
530 PAIN 438 0.0007
531 BLOOD PRESSURE INCREASED 108 0.0007
532 CATARACT 42 0.0007
533 THERAPY PARTIAL RESPONDER 11 0.0007
534 INABILITY TO AFFORD MEDICATION 7 0.0007
535 CHOLECYSTECTOMY 8 0.0007
536 SALIVARY HYPERSECRETION 7 0.0007
537 LIMB INJURY 19 0.0007
538 BURNING SENSATION 49 0.0007
539 SPINAL FRACTURE 14 0.0007
540 MUSCLE SPASMS 128 0.0007
541 SKIN CANCER 15 0.0007
542 EXERCISE TOLERANCE DECREASED 4 0.0007
543 CARDIAC MURMUR 6 0.0007
544 ULCER 11 0.0007
545 LIP SWELLING 23 0.0007
546 PRODUCT DISPENSING ERROR 15 0.0007
547 DRY THROAT 7 0.0007
548 ARTHRITIS 54 0.0007
549 BLOOD URINE PRESENT 13 0.0007
550 IMMUNE SYSTEM DISORDER 9 0.0007
551 ANKYLOSING SPONDYLITIS 9 0.0007
552 TOOTH INFECTION 9 0.0007
553 SARS-COV-2 TEST POSITIVE 9 0.0007
554 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 6 0.0007
555 LETHARGY 39 0.0007
556 LOWER LIMB FRACTURE 13 0.0007
557 AMNESIA 44 0.0007
558 DRUG INTOLERANCE 65 0.0007
559 CHOLECYSTITIS 8 0.0007
560 JOINT RANGE OF MOTION DECREASED 9 0.0007
561 IMMUNODEFICIENCY 10 0.0007
562 OROPHARYNGEAL PAIN 62 0.0007
563 MANIA 11 0.0007
564 DYSPHONIA 39 0.0007
565 BONE PAIN 39 0.0007
566 INJECTION SITE DISCOMFORT 7 0.0007
567 SKIN FISSURES 13 0.0007
568 HYPOPHAGIA 17 0.0007
569 GENERALISED TONIC-CLONIC SEIZURE 11 0.0007
570 DYSARTHRIA 25 0.0007
571 INJECTION SITE PAIN 203 0.0007
572 CONTRAINDICATED PRODUCT ADMINISTERED 20 0.0007
573 OPTIC NEURITIS 6 0.0007
574 FUNGAL INFECTION 22 0.0007
575 DISCOMFORT 40 0.0007
576 UPPER LIMB FRACTURE 13 0.0007
577 PROCEDURAL COMPLICATION 5 0.0007
578 DYSSTASIA 19 0.0007
579 ANGER 22 0.0006
580 RHINORRHOEA 42 0.0006
581 HEMIPARESIS 11 0.0006
582 THYROID DISORDER 10 0.0006
583 INCORRECT DOSE ADMINISTERED BY DEVICE 17 0.0006
584 LOW DENSITY LIPOPROTEIN INCREASED 5 0.0006
585 BACK INJURY 7 0.0006
586 PULMONARY THROMBOSIS 7 0.0006
587 OESOPHAGITIS 7 0.0006
588 ADVERSE EVENT 59 0.0006
589 INJECTION SITE REACTION 44 0.0006
590 URINARY TRACT INFECTION 109 0.0006
591 ELECTROCARDIOGRAM ABNORMAL 5 0.0006
592 BLOOD SODIUM DECREASED 12 0.0006
593 DERMATITIS ALLERGIC 8 0.0006
594 HYPERTENSIVE CRISIS 7 0.0006
595 OBESITY 10 0.0006
596 HYPERSENSITIVITY 116 0.0006
597 EPILEPSY 19 0.0006
598 NIGHT SWEATS 20 0.0006
599 STENT PLACEMENT 5 0.0006
600 INJECTION SITE RASH 19 0.0006
601 DIZZINESS POSTURAL 6 0.0006
602 MUSCLE TIGHTNESS 10 0.0006
603 PRESYNCOPE 15 0.0006
604 EMOTIONAL DISORDER 19 0.0006
605 HEPATIC ENZYME INCREASED 42 0.0006
606 IRRITABILITY 37 0.0006
607 INJECTION SITE BRUISING 49 0.0006
608 MICTURITION URGENCY 7 0.0006
609 FALL 203 0.0006
610 INFLUENZA 68 0.0006
611 TOOTHACHE 11 0.0006
612 SKIN HAEMORRHAGE 9 0.0006
613 DERMATITIS ATOPIC 32 0.0006
614 EMBEDDED DEVICE 6 0.0006
615 PRODUCT STORAGE ERROR 53 0.0006
616 MUSCULOSKELETAL STIFFNESS 53 0.0006
617 ELECTROLYTE IMBALANCE 7 0.0006
618 THERAPY NON-RESPONDER 27 0.0006
619 INJECTION SITE SWELLING 46 0.0006
620 HEART RATE DECREASED 21 0.0006
621 QUALITY OF LIFE DECREASED 8 0.0006
622 LACRIMATION INCREASED 18 0.0006
623 EYE PRURITUS 20 0.0006
624 INTENTIONAL PRODUCT MISUSE 52 0.0006
625 CONJUNCTIVITIS 11 0.0006
626 CANDIDA INFECTION 10 0.0006
627 BACTERIAL INFECTION 11 0.0006
628 SWELLING 55 0.0006
629 PRODUCTIVE COUGH 28 0.0006
630 ECCHYMOSIS 4 0.0006
631 GASTRIC DISORDER 20 0.0006
632 PARANOIA 10 0.0006
633 RASH PAPULAR 13 0.0006
634 VENTRICULAR EXTRASYSTOLES 6 0.0006
635 DIVERTICULITIS 16 0.0006
636 DEHYDRATION 77 0.0006
637 PETECHIAE 6 0.0006
638 TACHYCARDIA 51 0.0006
639 WEIGHT FLUCTUATION 6 0.0006
640 GLAUCOMA 11 0.0006
641 BLOOD CALCIUM INCREASED 5 0.0006
642 SCRATCH 6 0.0006
643 SMALL INTESTINAL OBSTRUCTION 7 0.0006
644 JOINT DISLOCATION 6 0.0006
645 RENAL PAIN 6 0.0006
646 ABDOMINAL PAIN 131 0.0006
647 INJECTION SITE DISCOLOURATION 7 0.0006
648 SYNCOPE 56 0.0006
649 FOREIGN BODY IN REPRODUCTIVE TRACT 5 0.0006
650 CEREBRAL HAEMORRHAGE 20 0.0006
651 GASTROINTESTINAL INFECTION 5 0.0006
652 PAIN OF SKIN 15 0.0006
653 BRAIN OEDEMA 7 0.0006
654 ABDOMINAL PAIN LOWER 14 0.0006
655 COMPLICATION ASSOCIATED WITH DEVICE 8 0.0006
656 ABORTION SPONTANEOUS 22 0.0005
657 INTRAOCULAR PRESSURE INCREASED 7 0.0005
658 NERVOUS SYSTEM DISORDER 17 0.0005
659 ACCIDENTAL EXPOSURE TO PRODUCT 56 0.0005
660 BACK PAIN 126 0.0005
661 BLOOD CHOLESTEROL INCREASED 25 0.0005
662 OSTEOPOROSIS 22 0.0005
663 INFLUENZA LIKE ILLNESS 44 0.0005
664 OFF LABEL USE 468 0.0005
665 JOINT STIFFNESS 14 0.0005
666 FLANK PAIN 5 0.0005
667 ARTHRALGIA 221 0.0005
668 MOVEMENT DISORDER 17 0.0005
669 CHILLS 62 0.0005
670 MENTAL DISORDER 23 0.0005
671 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 29 0.0005
672 MUSCULAR WEAKNESS 60 0.0005
673 ADVERSE REACTION 7 0.0005
674 NASOPHARYNGITIS 97 0.0005
675 PRODUCT PACKAGING ISSUE 5 0.0005
676 FLUSHING 53 0.0005
677 CHOLELITHIASIS 17 0.0005
678 RASH PRURITIC 28 0.0005
679 MALAISE 226 0.0005
680 APNOEA 4 0.0005
681 CHOKING 10 0.0005
682 GASTROINTESTINAL INFLAMMATION 4 0.0005
683 CENTRAL NERVOUS SYSTEM LESION 7 0.0005
684 RASH 221 0.0005
685 OCULAR HYPERAEMIA 24 0.0005
686 PRODUCT PRESCRIBING ISSUE 11 0.0005
687 HYPERHIDROSIS 65 0.0005
688 ISCHAEMIC STROKE 9 0.0005
689 INFLAMMATION 26 0.0005
690 BLADDER DISORDER 5 0.0005
691 GINGIVAL PAIN 4 0.0005
692 MACULAR DEGENERATION 6 0.0005
693 HYPOTHYROIDISM 16 0.0005
694 OVARIAN CYST 5 0.0005
695 BLOOD DISORDER 4 0.0005
696 THYROID CANCER 6 0.0005
697 ECZEMA 26 0.0005
698 WEIGHT INCREASED 111 0.0005
699 PELVIC PAIN 9 0.0005
700 NEUROPATHY PERIPHERAL 47 0.0005
701 COUGH 138 0.0005
702 GLOSSODYNIA 11 0.0005
703 SLUGGISHNESS 5 0.0005
704 MUSCLE SPASTICITY 6 0.0005
705 ABNORMAL FAECES 4 0.0005
706 CHROMATURIA 11 0.0005
707 INJECTION SITE MASS 18 0.0005
708 ESCHERICHIA INFECTION 4 0.0005
709 GENERALISED OEDEMA 6 0.0005
710 HYPERTHYROIDISM 7 0.0005
711 CYST 6 0.0005
712 PRODUCT AVAILABILITY ISSUE 11 0.0005
713 ILEUS 6 0.0005
714 INFUSION RELATED REACTION 32 0.0005
715 HYPOKINESIA 7 0.0005
716 EOSINOPHIL COUNT INCREASED 4 0.0005
717 APATHY 7 0.0005
718 TENDERNESS 5 0.0005
719 SKIN DISCOLOURATION 22 0.0005
720 HALLUCINATION 36 0.0005
721 PERIPHERAL SWELLING 73 0.0005
722 INCONTINENCE 5 0.0005
723 GAIT DISTURBANCE 90 0.0005
724 LUNG DISORDER 23 0.0005
725 RETCHING 10 0.0005
726 PAIN IN EXTREMITY 138 0.0005
727 BODY HEIGHT DECREASED 5 0.0005
728 CONTUSION 45 0.0005
729 ANAPHYLACTIC SHOCK 12 0.0005
730 DYSPNOEA 263 0.0005
731 RESTLESSNESS 17 0.0005
732 EXPOSURE VIA SKIN CONTACT 12 0.0005
733 PRODUCT PRESCRIBING ERROR 11 0.0005
734 HAEMORRHOIDS 9 0.0005
735 FLATULENCE 26 0.0005
736 BLOOD PRESSURE FLUCTUATION 11 0.0005
737 WOUND INFECTION 5 0.0005
738 GROIN PAIN 4 0.0005
739 WHEEZING 27 0.0005
740 DISORIENTATION 18 0.0005
741 BLOOD PRESSURE DECREASED 30 0.0005
742 HOT FLUSH 34 0.0005
743 INJECTION SITE HAEMORRHAGE 36 0.0005
744 COLITIS 17 0.0004
745 MENINGIOMA 7 0.0004
746 THROMBOSIS 36 0.0004
747 ASTHENIA 168 0.0004
748 ORAL PAIN 10 0.0004
749 GINGIVAL BLEEDING 6 0.0004
750 SCAB 5 0.0004
751 EXOSTOSIS 4 0.0004
752 INJECTION SITE ERYTHEMA 54 0.0004
753 INFECTION 63 0.0004
754 DRY SKIN 58 0.0004
755 METASTASES TO LUNG 5 0.0004
756 ORAL DISCOMFORT 6 0.0004
757 DYSGEUSIA 32 0.0004
758 CARDIAC DISORDER 40 0.0004
759 ARTERIOSCLEROSIS 4 0.0004
760 DYSPNOEA EXERTIONAL 16 0.0004
761 DIARRHOEA 274 0.0004
762 MYALGIA 72 0.0004
763 NERVOUSNESS 22 0.0004
764 GASTRIC ULCER 8 0.0004
765 HYPERLIPIDAEMIA 5 0.0004
766 HYPOACUSIS 18 0.0004
767 HERPES ZOSTER 24 0.0004
768 BLOOD GLUCOSE DECREASED 20 0.0004
769 AFFECT LABILITY 4 0.0004
770 PRODUCT USE IN UNAPPROVED INDICATION 103 0.0004
771 INCORRECT PRODUCT ADMINISTRATION DURATION 9 0.0004
772 CONDITION AGGRAVATED 126 0.0004
773 RHEUMATOID ARTHRITIS 47 0.0004
774 LOCALISED INFECTION 10 0.0004
775 CLOSTRIDIUM DIFFICILE INFECTION 9 0.0004
776 ADRENAL INSUFFICIENCY 5 0.0004
777 INTENTIONAL PRODUCT USE ISSUE 36 0.0004
778 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 7 0.0004
779 RENAL DISORDER 19 0.0004
780 GLOMERULAR FILTRATION RATE DECREASED 5 0.0004
781 PSYCHOTIC DISORDER 12 0.0004
782 SKIN EXFOLIATION 34 0.0004
783 CONFUSIONAL STATE 65 0.0004
784 ARRHYTHMIA 19 0.0004
785 BLOOD TRIGLYCERIDES INCREASED 7 0.0004
786 AGITATION 29 0.0004
787 PSORIATIC ARTHROPATHY 16 0.0004
788 INJECTION SITE IRRITATION 5 0.0004
789 DEVICE RELATED INFECTION 6 0.0004
790 LYMPHOMA 6 0.0004
791 OSTEOMYELITIS 7 0.0004
792 ANGINA PECTORIS 11 0.0004
793 PLATELET COUNT INCREASED 5 0.0004
794 FOETAL EXPOSURE DURING PREGNANCY 31 0.0004
795 MOUTH ULCERATION 8 0.0004
796 HALLUCINATION, VISUAL 8 0.0004
797 PNEUMOTHORAX 6 0.0004
798 HALLUCINATION, AUDITORY 6 0.0004
799 CYSTITIS 12 0.0004
800 INCORRECT DOSE ADMINISTERED 86 0.0004
801 RASH ERYTHEMATOUS 18 0.0004
802 SCIATICA 6 0.0004
803 BLISTER 21 0.0004
804 HYPOTENSION 75 0.0004
805 HIP FRACTURE 12 0.0004
806 DRUG INTERACTION 59 0.0004
807 FEAR 10 0.0004
808 SKIN IRRITATION 17 0.0004
809 DECREASED ACTIVITY 4 0.0004
810 UNDERDOSE 27 0.0004
811 RESPIRATORY DISORDER 11 0.0004
812 PALLOR 10 0.0004
813 BLOOD GLUCOSE FLUCTUATION 4 0.0004
814 ERYTHEMA 75 0.0004
815 MULTIPLE SCLEROSIS RELAPSE 25 0.0004
816 AGEUSIA 9 0.0004
817 WOUND 10 0.0004
818 WITHDRAWAL SYNDROME 15 0.0004
819 CELLULITIS 18 0.0004
820 DYSURIA 13 0.0004
821 HEPATOCELLULAR INJURY 5 0.0004
822 MOBILITY DECREASED 25 0.0003
823 PNEUMONIA 112 0.0003
824 MOOD SWINGS 11 0.0003
825 PULMONARY ARTERIAL HYPERTENSION 5 0.0003
826 HAEMATOCHEZIA 19 0.0003
827 IMPAIRED HEALING 11 0.0003
828 EPISTAXIS 25 0.0003
829 COMPLICATION OF DEVICE REMOVAL 6 0.0003
830 SEPSIS 37 0.0003
831 LEUKOCYTOSIS 6 0.0003
832 BURSITIS 4 0.0003
833 URINARY RETENTION 11 0.0003
834 OSTEOPENIA 5 0.0003
835 DIABETES MELLITUS 25 0.0003
836 RESPIRATORY DISTRESS 9 0.0003
837 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 17 0.0003
838 HOSPITALISATION 50 0.0003
839 MUSCULOSKELETAL CHEST PAIN 5 0.0003
840 MYOCARDIAL INFARCTION 55 0.0003
841 POLLAKIURIA 13 0.0003
842 SENSORY DISTURBANCE 5 0.0003
843 ERUCTATION 6 0.0003
844 HEART RATE IRREGULAR 7 0.0003
845 SKIN ULCER 8 0.0003
846 ALANINE AMINOTRANSFERASE INCREASED 19 0.0003
847 ATRIAL FIBRILLATION 30 0.0003
848 SKIN BURNING SENSATION 22 0.0003
849 URINARY INCONTINENCE 9 0.0003
850 PRESCRIBED UNDERDOSE 6 0.0003
851 SEPTIC SHOCK 13 0.0003
852 BLOOD UREA INCREASED 5 0.0003
853 TYPE 2 DIABETES MELLITUS 10 0.0003
854 PULMONARY EMBOLISM 28 0.0003
855 DISEASE RECURRENCE 14 0.0003
856 ACUTE HEPATIC FAILURE 4 0.0003
857 PRODUCT PREPARATION ERROR 6 0.0003
858 SKIN LESION 8 0.0003
859 DEVICE DEFECTIVE 5 0.0003
860 DELIRIUM 10 0.0003
861 COORDINATION ABNORMAL 4 0.0003
862 CEREBRAL INFARCTION 7 0.0003
863 DERMATITIS 6 0.0003
864 PYREXIA 99 0.0003
865 TARDIVE DYSKINESIA 8 0.0003
866 OSTEOARTHRITIS 12 0.0003
867 MULTIPLE ORGAN DYSFUNCTION SYNDROME 8 0.0003
868 ASPARTATE AMINOTRANSFERASE INCREASED 15 0.0003
869 GALLBLADDER DISORDER 5 0.0003
870 FAECES DISCOLOURED 6 0.0003
871 VAGINAL HAEMORRHAGE 12 0.0003
872 ANOSMIA 4 0.0003
873 C-REACTIVE PROTEIN INCREASED 10 0.0003
874 NEEDLE ISSUE 8 0.0003
875 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 8 0.0003
876 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 5 0.0003
877 DYSKINESIA 11 0.0003
878 CARDIOMYOPATHY 4 0.0003
879 SKIN DISORDER 9 0.0003
880 HAEMORRHAGE INTRACRANIAL 4 0.0003
881 BRADYCARDIA 14 0.0003
882 ECONOMIC PROBLEM 4 0.0003
883 INCREASED APPETITE 5 0.0003
884 PULMONARY FIBROSIS 5 0.0003
885 SEROTONIN SYNDROME 5 0.0003
886 OEDEMA 14 0.0003
887 DYSTONIA 5 0.0003
888 BREAST CANCER 24 0.0003
889 EXPOSURE DURING PREGNANCY 16 0.0003
890 BASAL CELL CARCINOMA 4 0.0003
891 BLOOD PRESSURE SYSTOLIC INCREASED 5 0.0003
892 DEVICE DELIVERY SYSTEM ISSUE 7 0.0003
893 FLUID RETENTION 13 0.0003
894 CYANOSIS 4 0.0003
895 PSORIASIS 33 0.0003
896 DEMENTIA 7 0.0003
897 CHRONIC KIDNEY DISEASE 19 0.0002
898 FULL BLOOD COUNT DECREASED 5 0.0002
899 COLITIS ULCERATIVE 11 0.0002
900 INJURY ASSOCIATED WITH DEVICE 5 0.0002
901 LUNG NEOPLASM MALIGNANT 10 0.0002
902 STAPHYLOCOCCAL INFECTION 8 0.0002
903 EXPIRED PRODUCT ADMINISTERED 8 0.0002
904 PULMONARY HYPERTENSION 5 0.0002
905 GLYCOSYLATED HAEMOGLOBIN INCREASED 6 0.0002
906 PRODUCT COMPLAINT 6 0.0002
907 HAEMATEMESIS 6 0.0002
908 CARDIOVASCULAR DISORDER 6 0.0002
909 WHITE BLOOD CELL COUNT INCREASED 9 0.0002
910 JOINT SWELLING 28 0.0002
911 OXYGEN SATURATION DECREASED 13 0.0002
912 STOMATITIS 14 0.0002
913 DEVICE DISLOCATION 10 0.0002
914 RASH MACULAR 8 0.0002
915 COMPLETED SUICIDE 19 0.0002
916 ABNORMAL BEHAVIOUR 9 0.0002
917 FEMUR FRACTURE 7 0.0002
918 JAUNDICE 6 0.0002
919 FREQUENT BOWEL MOVEMENTS 6 0.0002
920 DEVICE BREAKAGE 9 0.0002
921 HAEMORRHAGE 23 0.0002
922 HYPERGLYCAEMIA 8 0.0002
923 MENTAL STATUS CHANGES 6 0.0002
924 ACUTE MYOCARDIAL INFARCTION 6 0.0002
925 DEVICE USE ERROR 7 0.0002
926 ANAEMIA 38 0.0002
927 SUICIDE ATTEMPT 12 0.0002
928 ERECTILE DYSFUNCTION 5 0.0002
929 DRUG RESISTANCE 5 0.0002
930 UNRESPONSIVE TO STIMULI 5 0.0002
931 TREATMENT FAILURE 16 0.0002
932 HAEMATOMA 5 0.0002
933 ACCIDENTAL OVERDOSE 7 0.0002
934 RENAL IMPAIRMENT 16 0.0002
935 EMOTIONAL DISTRESS 23 0.0002
936 DEVICE MALFUNCTION 13 0.0002
937 ACNE 14 0.0002
938 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 6 0.0002
939 DEPRESSED LEVEL OF CONSCIOUSNESS 7 0.0002
940 LOWER RESPIRATORY TRACT INFECTION 8 0.0002
941 WHITE BLOOD CELL COUNT DECREASED 19 0.0002
942 HAEMATURIA 6 0.0002
943 PRODUCT SUBSTITUTION ISSUE 10 0.0002
944 HYPOKALAEMIA 8 0.0002
945 INJURY 12 0.0002
946 DEEP VEIN THROMBOSIS 11 0.0002
947 BLOOD CREATININE INCREASED 11 0.0002
948 COMA 8 0.0002
949 ANGIOEDEMA 7 0.0002
950 LIVER DISORDER 7 0.0002
951 OEDEMA PERIPHERAL 19 0.0002
952 PRODUCT QUALITY ISSUE 21 0.0002
953 ANHEDONIA 4 0.0002
954 PANCREATITIS 8 0.0002
955 DEATH 129 0.0001
956 CARDIAC FAILURE CONGESTIVE 12 0.0001
957 TREATMENT NONCOMPLIANCE 8 0.0001
958 DEVICE ISSUE 13 0.0001
959 MEDICATION ERROR 8 0.0001
960 HAEMOPTYSIS 4 0.0001
961 AGGRESSION 7 0.0001
962 DEVICE LEAKAGE 6 0.0001
963 BLOOD GLUCOSE INCREASED 25 0.0001
964 NO ADVERSE EVENT 24 0.0001
965 ILL-DEFINED DISORDER 8 0.0001
966 BONE DENSITY DECREASED 4 0.0001
967 ARTHROPATHY 7 0.0001
968 EXTRA DOSE ADMINISTERED 5 0.0001
969 PLATELET COUNT DECREASED 13 0.0001
970 RECTAL HAEMORRHAGE 5 0.0001
971 PLEURAL EFFUSION 7 0.0001
972 MUSCULOSKELETAL PAIN 6 0.0001
973 RESPIRATORY FAILURE 8 0.0001
974 HYPOGLYCAEMIA 5 0.0001
975 CARDIAC FAILURE 8 0.0001
976 HAEMOGLOBIN DECREASED 10 0.0001
977 GENERAL PHYSICAL HEALTH DETERIORATION 11 0.0001
978 DRUG WITHDRAWAL SYNDROME 8 0.0001
979 ACUTE KIDNEY INJURY 13 0.0001
980 DEVICE EXPULSION 5 0.0001
981 DISEASE PROGRESSION 9 0.0001
982 RENAL FAILURE 10 0.0001
983 PROSTATE CANCER 6 0.0001
984 OVERDOSE 16 0.0001
985 CARDIAC ARREST 5 0.0001
986 GASTROINTESTINAL HAEMORRHAGE 4 0.0000
987 TOXICITY TO VARIOUS AGENTS 8 0.0000
988 DRUG DEPENDENCE 5 0.0000